Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $94,965 - $122,493
-12,021 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$8.38 - $10.18 $100,735 - $122,373
12,021 New
12,021 $117,000
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $107,225 - $132,839
-10,370 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $1,291 - $1,655
150 Added 1.47%
10,370 $100,000
Q3 2020

Nov 04, 2020

SELL
$8.57 - $12.69 $21,425 - $31,725
-2,500 Reduced 19.65%
10,220 $92,000
Q2 2020

Aug 06, 2020

SELL
$8.12 - $13.12 $3,369 - $5,444
-415 Reduced 3.16%
12,720 $157,000
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $87,873 - $176,665
13,135 New
13,135 $118,000
Q3 2017

Nov 15, 2017

SELL
$15.41 - $32.17 $101,952 - $212,836
-6,616 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
6,616
6,616 $206,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.